Skip to content
NYSE · SERVICES-MEDICAL LABORATORIES · SMALL CAP

American Shared Hospital Services AMS

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$28.1M
▼ 0.9% YoY
$-1.6M
▼ 171.0% YoY
$-4.5M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

The Company delivers radiation therapy through medical equipment leasing and direct patient services, its two reportable segments. The Company currently provides Gamma Knife services through its 81% indirect interest in GK Financing, LLC, a California limited liability company (“GKF”) to seven medical centers in eight states in the United States, and owns and operates two Gamma Knife units at stand-alone facilities in Lima, Peru and Guayaquil, Ecuador. The remaining 19% of GKF is owned by GKV Investments, Inc. (“GKV Investments”), a wholly-owned U.S. subsidiary of Elekta AG, a Swedish company (“Elekta”). The Company wholly-owns the subsidiaries American Shared Radiosurgery Services (“ASRS”), ASHS-Mexico, S.A. de C.V. (“ASHS-Mexico”), ASHS-Rhode Island Proton Beam Radiation Therapy, LLC (“RI PBRT”), ASHS-Bristol Radiation Therapy, LLC (“Bristol”), OR21, Inc. and MedLeader.com, Inc. (“MedLeader”).

Written from the business description in American Shared Hospital Services's annual report to the U.S. Securities and Exchange Commission, filed 31 March 2026. Every sentence was checked against that document before publication.

Growth

USD 28.1M
Revenue, FY2025 · full 17-year series below
Revenue $M Net income $M
FY2025 · Revenue 28.1 · Net income -1.6
10.0M20.0M-2.5M-5.0M
2009201220152018202120242025
Compound annual growth
+12.5%
+9.5%
+5.4%
+3.5%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +9.5% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−10 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -12.8% · Net -9.7%
5%10%15%-20%-40%
200920172025
ROE
FY2025 · ROE -6.3%
5%-10%-20%-30%
200920172025
Three returns, three denominators.

Each USD of equity lost 6 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -4.5
4M8M-3M-6M
200920172025
Net buybacks $ Dividends $
FY2016 · Dividends · · Net buybacks 0.0
100000200000
20092010201120122013201420152016

Total assetsUSD 55.5M
EquityUSD 24.0M
CashUSD 3.5M
Gross debtUSD 17.3M
Net debtUSD 13.8M
Current ratio0.76×

Net debt stands at 58% of equity.

The 17-year record

17 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
AMS, 17-year financial record
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.00.00.00.0−0.00.00.00.00.00.0−0.00.00.00.00.00.0
EBITDA $B◌◌0.00.00.0−0.00.00.00.00.00.00.00.00.00.00.00.0
Income tax $B−0.0−0.00.00.00.0−0.00.00.0−0.00.00.00.00.00.00.00.00.0
Net income $B−0.00.00.00.00.0−0.00.00.00.00.0−0.0−0.0−0.00.00.00.0−0.0
Free cash flow $B−0.0−0.0−0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
EPS, diluted $−0.230.330.100.210.03−1.140.110.170.330.17−0.28−0.19−0.070.010.110.01−0.04
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend—————————————————
ROE %−6.39.12.86.41.0−31.22.64.28.54.5−7.3−4.6−1.60.22.50.3◌
Shares out B0.010.010.010.010.010.010.010.010.010.010.010.010.000.000.000.00◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 81 reconciliationsAUDITED

Reconciled in 17 of the 17 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: the share count is not tagged before 2010. Two checks were skipped: revenue is not tagged before 2009.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Medical Laboratories
Listed onNYSE
Incorporated inCalifornia
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2009

Share this section

Download image